Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Poseida Therapeutics
company
About
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
- 251 - 500
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $23M
- Industries
- Biopharma,Biotechnology,Genetics,Therapeutics
- Founded date
- Jan 1, 2014
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous and allogeneic chimeric antigen receptor T cell or CAR-T, product candidates focusing on the treatment of hematological malignancies and solid tumors.Poseida Therapeutics was founded in 2014 and is headquartered in San Diego, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$206.66M
Poseida Therapeutics has raised a total of
$206.66M
in funding over 2 rounds. Their latest funding was raised on
Apr 22, 2019 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 22, 2019 | Series C | $142M | 1 | — | — | Detail |
| Apr 3, 2018 | Series B | $30.50M | 1 | — | — | Detail |
| Aug 2, 2017 | Series A | $11.16M | 1 |
Malin Corporation
|
— | Detail |
| Dec 23, 2015 | Series A | $23M | 1 |
Malin Corporation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Poseida Therapeutics is funded by 1 investors.
Malin Corporation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Malin Corporation
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
